KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to Michigan

HB5051 • 2026

Health: pharmaceuticals; administration of epinephrine; modify. Amends title & secs. 1, 2 & 3 of 2020 PA 312 (MCL 28.821 et seq.). TIE BAR WITH: HB 5054'25, HB 5049'25, HB 5050'25, HB 5052'25, HB 5053'25

Health: pharmaceuticals; administration of epinephrine; modify. Amends title & secs. 1, 2 & 3 of 2020 PA 312 (MCL 28.821 et seq.). TIE BAR WITH: HB 5054'25, HB 5049'25, HB 5050'25, HB 5052'25, HB 5053'25

Active

The official status still shows this bill as active or still awaiting another formal step.

Sponsor
Nancy DeBoer (District 86), Will Snyder (District 87), Joseph Pavlov (District 64), Regina Weiss (District 5), Mai Xiong (District 13), Morgan Foreman (District 33), Penelope Tsernoglou (District 75), Brian BeGole (District 71), Kathy Schmaltz (District 46), Thomas Kuhn (District 57), Steve Frisbie (District 44), Nancy Jenkins-Arno (District 34), Luke Meerman (District 89), Matt Bierlein (District 97), Brenda Carter (District 53), Jason Hoskins (District 18), Karl Bohnak (District 109), David Prestin (District 108), Alicia St. Germaine (District 62), Mark Tisdel (District 55)
Last action
2026-01-14
Official status
REFERRED TO COMMITTEE ON HEALTH POLICY
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Health: pharmaceuticals; administration of epinephrine; modify. Amends title & secs. 1, 2 & 3 of 2020 PA 312 (MCL 28.821 et seq.). TIE BAR WITH: HB 5054'25, HB 5049'25, HB 5050'25, HB 5052'25, HB 5053'25

Health: pharmaceuticals; administration of epinephrine; modify.

What This Bill Does

  • Health: pharmaceuticals; administration of epinephrine; modify.
  • Amends title & secs.
  • 1, 2 & 3 of 2020 PA 312 (MCL 28.821 et seq.).
  • TIE BAR WITH: HB 5054'25, HB 5049'25, HB 5050'25, HB 5052'25, HB 5053'25

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-01-14 SJ 1 Pg. 6

    PASSED BY HOUSE WITH IMMEDIATE EFFECT

  2. 2026-01-14 SJ 1 Pg. 6

    REFERRED TO COMMITTEE ON HEALTH POLICY

  3. 2025-12-17 HJ 116 Pg. 1973

    read a third time

  4. 2025-12-17 HJ 116 Pg. 1973

    passed; given immediate effect Roll Call #354 Yeas 103 Nays 0 Excused 0 Not Voting 7

  5. 2025-12-17 HJ 116 Pg. 1973

    transmitted

  6. 2025-12-16 HJ 115 Pg. 1933

    read a second time

  7. 2025-12-16 HJ 115 Pg. 1933

    placed on third reading

  8. 2025-11-05 HJ 107 Pg. 1783

    reported with recommendation without amendment

  9. 2025-11-05 HJ 107 Pg. 1783

    referred to second reading

  10. 2025-09-25 HJ 87 Pg. 1032

    bill electronically reproduced 09/24/2025

  11. 2025-09-24 HJ 86 Pg. 1026

    introduced by Representative Rep. Nancy DeBoer

  12. 2025-09-24 HJ 86 Pg. 1026

    read a first time

  13. 2025-09-24 HJ 86 Pg. 1026

    referred to Committee on Education and Workforce

Official Summary Text

Health: pharmaceuticals; administration of epinephrine; modify. Amends title & secs. 1, 2 & 3 of 2020 PA 312 (MCL 28.821 et seq.). TIE BAR WITH: HB 5054'25, HB 5049'25, HB 5050'25, HB 5052'25, HB 5053'25